6N9N

Crystal structure of murine GSDMD


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.3 Å
  • R-Value Free: 0.321 
  • R-Value Work: 0.261 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization.

Liu, Z.Wang, C.Yang, J.Zhou, B.Yang, R.Ramachandran, R.Abbott, D.W.Xiao, T.S.

(2019) Immunity 51: 43

  • DOI: 10.1016/j.immuni.2019.04.017
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • Gasdermin D (GSDMD) is an effector molecule for pyroptosis downstream of canonical and noncanonical inflammasome signaling pathways. Cleavage of GSDMD by inflammatory caspases triggers the oligomerization and lipid binding by its N-terminal domain, w ...

    Gasdermin D (GSDMD) is an effector molecule for pyroptosis downstream of canonical and noncanonical inflammasome signaling pathways. Cleavage of GSDMD by inflammatory caspases triggers the oligomerization and lipid binding by its N-terminal domain, which assembles membrane pores, whereas its C-terminal domain binds the N-terminal domain to inhibit pyroptosis. Despite recent progress in our understanding of the structure and function of the murine gasdermin A3 (mGSDMA3), the molecular mechanisms of GSDMD activation and regulation remain poorly characterized. Here, we report the crystal structures of the full-length murine and human GSDMDs, which reveal the architecture of the GSDMD N-terminal domains and demonstrate distinct and common features of autoinhibition among gasdermin family members utilizing their β1-β2 loops. Disruption of the intramolecular domain interface enhanced pyroptosis, whereas mutations at the predicted lipid-binding or oligomerization surface reduced cytolysis. Our study provides a framework for understanding the autoinhibition, lipid binding, and oligomerization of GSDMD by using overlapping interfaces.


    Organizational Affiliation

    Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106 USA; Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, OH 44106 USA.,Department of Biology, Case Western Reserve University, Cleveland, OH 44106 USA.,Department of Pathology, Case Western Reserve University, Cleveland, OH 44106 USA; Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, OH 44106 USA. Electronic address: tsx@case.edu.,Department of Pathology, Case Western Reserve University, Cleveland, OH 44106 USA; Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106 USA.,Department of Pathology, Case Western Reserve University, Cleveland, OH 44106 USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Gasdermin-D
A, B
488Mus musculusMutation(s): 0 
Gene Names: Gsdmdc1 (Gsdmd)
Find proteins for Q9D8T2 (Mus musculus)
Go to UniProtKB:  Q9D8T2
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.3 Å
  • R-Value Free: 0.321 
  • R-Value Work: 0.261 
  • Space Group: P 1 21 1
Unit Cell:
Length (Å)Angle (°)
a = 66.420α = 90.00
b = 86.840β = 95.27
c = 83.540γ = 90.00
Software Package:
Software NamePurpose
XSCALEdata scaling
PHENIXphasing
PHENIXrefinement
XDSdata reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)United StatesGM127609
National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)United StatesAR069908

Revision History 

  • Version 1.0: 2019-06-05
    Type: Initial release
  • Version 1.1: 2019-07-31
    Type: Data collection, Database references
  • Version 1.2: 2019-12-11
    Type: Author supporting evidence